These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7543059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.
    Niitsu N, Umeda M.
    Eur J Haematol; 1996 Mar; 56(3):163-7. PubMed ID: 8598236
    [Abstract] [Full Text] [Related]

  • 3. [COP-BLAM III regimen for elderly non-Hodgkin's lymphoma].
    Niitsu N, Umeda M, Shirai T.
    Nihon Ronen Igakkai Zasshi; 1993 Sep; 30(9):753-8. PubMed ID: 7693992
    [Abstract] [Full Text] [Related]

  • 4. [The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma].
    Niitsu N, Umeda M.
    Rinsho Ketsueki; 1995 Feb; 36(2):84-90. PubMed ID: 7536279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Usefulness of COP-BLAM therapy with concomitant G-CSF in elderly patients with non-Hodgkin's lymphoma in comparison with patients not given G-CSF].
    Niitsu N, Umeda M.
    Nihon Ronen Igakkai Zasshi; 1995 Jun; 32(6):410-5. PubMed ID: 7563935
    [Abstract] [Full Text] [Related]

  • 8. Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.
    Engelhard M, Gerhartz H, Brittinger G, Engert A, Fuchs R, Geiseler B, Gerhartz D, Haunauske AR, Hartlapp HJ, Huhn D.
    Ann Oncol; 1994 Jun; 5 Suppl 2():123-5. PubMed ID: 7515644
    [Abstract] [Full Text] [Related]

  • 9. Biweekly THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate- and high-grade non-Hodgkins's lymphoma.
    Niitsu N, Umeda M.
    Leukemia; 1998 Sep; 12(9):1457-60. PubMed ID: 9737696
    [Abstract] [Full Text] [Related]

  • 10. [Assessment of cardiac toxicity by 123I-MIBG myocardial SPECT in elderly non-Hodgkin lymphoma patients treated with COP-BLAM and G-CSF].
    Niitsu N, Umeda M.
    Rinsho Ketsueki; 1995 Nov; 36(11):1326-8. PubMed ID: 8691577
    [Abstract] [Full Text] [Related]

  • 11. The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.
    Coleman M, Armitage JO, Gaynor M, McDermott D, Weisenburger DD, Adler K, Beshevkin M, Silver RT, Reisman AM, Pasmantier MW.
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):23-33. PubMed ID: 2456620
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
    Niitsu N, Hara A, Umeda M, Shirai T.
    Rinsho Ketsueki; 1993 Jul; 34(7):829-34. PubMed ID: 7689661
    [Abstract] [Full Text] [Related]

  • 16. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas.
    Gerhartz HH, Engelhard M, Meusers P, Brittinger G, Wilmanns W, Schlimok G, Mueller P, Huhn D, Musch R, Siegert W.
    Blood; 1993 Oct 15; 82(8):2329-39. PubMed ID: 7691256
    [Abstract] [Full Text] [Related]

  • 17. THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: a prospective study.
    Niitsu N, Umeda M.
    Leukemia; 1997 Nov 15; 11(11):1817-20. PubMed ID: 9369412
    [Abstract] [Full Text] [Related]

  • 18. The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients.
    Shpilberg O, Shiff J, Chetrit A, Ramot B, Ben-Bassat I.
    Cancer; 1994 Dec 01; 74(11):3029-33. PubMed ID: 7525042
    [Abstract] [Full Text] [Related]

  • 19. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 20. Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma.
    Zinzani PL, Martelli M, Tura S, Mandelli F.
    Haematologica; 1993 May 01; 78(1):40-3. PubMed ID: 7684011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.